It offers participants the opportunity to educate themselves about the risks of breast cancer and ways to reduce those risks. Volunteers will be paid for their participation. Volunteers are also needed for a Phase I study of patients who have been treated for gastrointestinal malignancies. Patients who have had one or more treatments and have recovered from all side effects of the treatments are eligible to participate. Eligible participants will be provided physical examinations by board-certified dermatologists, laboratory tests and medication at no cost.
Some programs have monetary compensation.
The study will evaluate its safety and effectiveness for children who have epilepsy characterized by partial-onset seizures. Topiramate works differently from other anticonvulsants and may be useful in controlling this type of seizure. To be eligible, participants must be between the ages of 3 and 18 and have been diagnosed with partial-onset seizures within the past two years. Topiramate will be provided at no charge until the drug is marketed. In an effort to learn more about why diabetes affects this group, participants will be asked to answer a questionnaire.